Sumitomo Pharma Co. Ltd. (DNPUF)

PNK: DNPUF · Real-Time Price · USD

5.80

1.70 (41.46%)

At close: May 01, 2025, 9:30 AM

Sumitomo Pharma Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Cash & Equivalents	29.05B	143.48B	202.98B	193.7B	101.71B	137.3B	147.78B	71.41B	54.92B
Short-Term Investments	7.08B	20.17B	35.6B	29.48B	28.72B	43.75B	22.07B	34.2B	81.04B
Long-Term Investments	182.37B	113.83B	80.25B	163.56B	172.21B	30.92B	48.93B	13.84B	-20.61B
Other Long-Term Assets	2.24B	30.57B	47.66B	39.72B	32.89B	49.59B	27.59B	39.38B	86.02B
Receivables	81.02B	95.91B	151.41B	135.87B	134.49B	118.76B	112.98B	110.93B	107.16B
Inventory	115.35B	94.41B	99.02B	92.22B	79.37B	66.89B	60.17B	68.81B	59.59B
Other Current Assets	37.06B	48.07B	46.11B	38.02B	48.52B	50.32B	27.66B	91.12B	118.88B
Total Current Assets	269.57B	381.86B	499.52B	459.8B	364.09B	373.27B	348.58B	376.45B	421.58B
Property-Plant & Equipment	57.9B	58.91B	64.09B	64.97B	65.75B	59.48B	58.2B	59.25B	61.82B
Goodwill & Intangibles	395.44B	538.73B	593.84B	559.9B	590.84B	270.74B	284.78B	304.31B	156.58B
Total Long-Term Assets	637.94B	752.88B	808.49B	848.33B	888.79B	461.45B	461.1B	417.49B	286.13B
Total Assets	907.51B	1,134.7B	1,308B	1,308.1B	1,252.9B	834.72B	809.68B	793.95B	707.72B
Account Payables	67.72B	52.14B	46.18B	64.64B	62.25B	49.24B	58.71B	4.51B	43.53B
Deferred Revenue	n/a	151.95B	140.03B	147.7B	121.19B	116.57B	105.08B	133.76B	129.69B
Short-Term Debt	285.52B	90.59B	25.09B	9.96B	272.96B	2.96B	16.46B	58B	23.01B
Other Current Liabilities	158.46B	76.21B	61.61B	49.95B	40.1B	29.4B	30B	11.19B	4.06B
Total Current Liabilities	515.47B	372.69B	278.37B	278.15B	496.5B	198.17B	210.25B	228.45B	179.72B
Long-Term Debt	133.37B	244.13B	243.96B	263.86B	25.02B	27.98B	30.94B	10B	28B
Other Long-Term Liabilities	102.53B	52.57B	74.14B	70.51B	34.08B	110.42B	6.65B	81.35B	37.36B
Total Long-Term Liabilities	235.9B	355.27B	356.06B	381.8B	124.28B	138.41B	146.71B	104.85B	81.52B
Total Liabilities	751.37B	727.96B	634.44B	659.95B	620.77B	336.58B	356.96B	333.29B	261.24B
Total Debt	427.86B	334.72B	269.05B	273.82B	297.98B	30.94B	47.4B	68B	51.01B
Common Stock	22.4B	22.4B	22.4B	22.4B	22.4B	22.4B	22.4B	22.4B	22.4B
Retained Earnings	-22.66B	281B	514.21B	508.68B	457.33B	431.8B	396.04B	363.63B	341.4B
Comprehensive Income	n/a	104.03B	55.23B	34.32B	35.78B	28.75B	19.09B	16.91B	67.47B
Shareholders Equity	156.06B	406.75B	607.89B	580.57B	529.49B	498.14B	452.72B	460.66B	446.47B
Total Investments	161.71B	134.01B	115.84B	193.03B	200.92B	74.67B	70.99B	48.03B	60.43B